ArticleJournal for immunotherapy of cancer2021

Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer.

Sebastian Marwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.